Skip to main content
logo
Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
4.190
+0.110 (2.70%)
Sep 18, 2026, 3:53 PM EDT - Market open

Whitehawk Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
2391147850313505
Market Cap Growth
159.92%46.66%56.96%-84.17%-37.97%-
Enterprise Value
49-4916-68132344
Last Close Price
4.082.423.152.0212.8324.15

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
-15.962.992.0320.57450.53
PB Ratio
1.270.841.480.471.983.70
P/TBV Ratio
1.290.841.480.471.983.81

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
--0.62-8.66306.99

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
--0.020.010.010.00
Net Debt / Equity Ratio
-1.04-1.07-0.88-1.02-1.08-1.09
Net Debt / EBITDA Ratio
2.211.270.721.502.914.01
Net Debt / FCF Ratio
2.741.490.761.693.416.60
Asset Turnover
-0.070.260.150.090.01
Inventory Turnover
--0.5212.49--
Quick Ratio
17.1610.043.114.339.269.76
Current Ratio
17.3810.263.594.729.569.90
Return on Equity (ROE)
-44.98%-21.82%-80.79%-49.90%-41.06%-177.60%
Return on Assets (ROA)
-28.70%-64.66%-39.96%-28.39%-21.54%-26.21%
Return on Capital Employed (ROCE)
-47.00%-83.90%-121.70%-67.80%-35.60%-26.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-33.91%-18.06%-81.90%-132.75%-19.33%-21.82%
FCF Yield
-29.45%-85.91%-78.71%-128.45%-16.00%-4.45%
Buyback Yield / Dilution
-78.42%-128.96%-0.42%-19.58%-152.27%-250.99%
SEC Filings: 10-K · 10-Q